These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2498967)

  • 1. Serotonin-influencing drugs in the treatment of panic disorder.
    Westenberg HG; den Boer JA
    Psychopathology; 1989; 22 Suppl 1():68-77. PubMed ID: 2498967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.
    Den Boer JA; Westenberg HG
    Int Clin Psychopharmacol; 1988 Jan; 3(1):59-74. PubMed ID: 2833543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Den Boer JA; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):85-94. PubMed ID: 1697419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin antagonism in panic disorder: an open trial with ritanserin.
    Griez E; Pols H; Lousberg H
    Acta Psychiatr Belg; 1988; 88(5-6):372-7. PubMed ID: 3152708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
    den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
    Norman TR; Gregory MS; Judd FK; Burrows GD; McIntyre IM
    Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.
    den Boer JA; Westenberg HG; Kamerbeek WD; Verhoeven WM; Kahn RS
    Int Clin Psychopharmacol; 1987 Jan; 2(1):21-32. PubMed ID: 3117876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
    Pohl R; Balon R; Yeragani VK; Gershon S
    Psychopathology; 1989; 22 Suppl 1():60-7. PubMed ID: 2657839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM; Rubin RT; Rifkin A; Swinson RP; Ballenger JC; Burrows GD; Dupont RL; Noyes R; Pecknold JC
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Panic attacks and agoraphobia: low dose clomipramine treatment.
    Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
    J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.
    Evans L; Kenardy J; Schneider P; Hoey H
    Acta Psychiatr Scand; 1986 Jan; 73(1):49-53. PubMed ID: 2938422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D; Bailly D; Le Seac'h H; Parquet PJ
    Encephale; 1990; 16 Spec No():359-62. PubMed ID: 2120029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W; Noyes R
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
    Pollack MH; Tesar GE; Rosenbaum JF; Spier SA
    J Clin Psychopharmacol; 1986 Oct; 6(5):302-4. PubMed ID: 3771814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract]   [Full Text] [Related]  

  • 18. Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Usigli R; Zulueta A; Crocker B; Adatia N; Buckwalter JG; Baltazar P; Kurvink W; Inglove H; Kelly R
    J Clin Psychopharmacol; 1988 Jun; 8(3):204-7. PubMed ID: 3379145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE; Greenberg HS
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.